Spero Therapeutics, Inc.

SPRONasdaq· Pharmaceutical Preparations

Price History

Revenue

$371,000

▼ 60.2% YoY

Net Income

-$68.6M

▼ 400.6% YoY

EPS

$-1.27

▼ 395.3% YoY

Cash

$52.9M

▼ 30.7% YoY

FY 2024 · As of 2024-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.